Junfa Yang
Anhui Province Key Laboratory Of Major Autoimmune Diseases
Hefei, China
Hefei, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 22 publications
6-Gingerol alleviates hepatic fibrosis via inhibiting glycolytic reprogramming by targeting IGF2BP2.
6-Gingerol alleviates hepatic fibrosis via inhibiting glycolytic reprogramming by targeting IGF2BP2.
Journal: Chinese herbal medicines
Published: October 31, 2025
SIRT1 in Liver Diseases: Mechanistic Insights and Therapeutic Prospects.
Journal: International journal of biological sciences
Published: May 16, 2025
Organoid technologies in antitumor drug screening: past development, present applications, and future prospects.
Journal: International journal of surgery (London, England)
Published: November 21, 2024
Research Progress on the Correlation between Acetaldehyde Dehydrogenase 2 and Hepatocellular Carcinoma Development.
Journal: The Journal of pharmacology and experimental therapeutics
Published: August 24, 2023
Puerarin inhibits inflammation and lipid accumulation in alcoholic liver disease through regulating MMP8.
Journal: Chinese journal of natural medicines
Published: November 23, 2022
Role of microRNA alternation in the pathogenesis of gouty arthritis.
Journal: Frontiers in endocrinology
Published: June 13, 2022
Puerarin Prevents Acute Liver Injury via Inhibiting Inflammatory Responses and ZEB2 Expression.
Journal: Frontiers in pharmacology
Published: June 20, 2021
Corrigendum to "Paeonol derivative-6 attenuates inflammation by activating ZEB2 in acute liver injury" [Int. Immunopharmacol. 91 (2021) 107235].
Journal: International immunopharmacology
Published: February 12, 2021
Rev-erbα exacerbates hepatic steatosis in alcoholic liver diseases through regulating autophagy.
Journal: Cell & bioscience
Published: January 22, 2021
A Review of SARS-CoV2: Compared With SARS-CoV and MERS-CoV.
Journal: Frontiers in medicine
Published: January 13, 2021
Last Updated: 09/26/2026